Skip to content

The effectiveness of different modalities of cueing in overground walking in people with Parkinson*s disease

The effectiveness of different modalities of cueing in overground walking in people with Parkinson*s disease - Effectiveness of cueing in overground walking in people with PD.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46557
Enrollment
15
Registered
2018-05-15
Start date
2018-06-06
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Patients walk with external rhythmic cues

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Ambulatory patients showing mild to severe gait disturbance with score >1 on the Unified Parkinson*s Disease Rating scale (UPDRS; motor section) Idiopathic Parkinson*s disease stable drug usage Moderate disease severity (Hoehn and Yahr stage II-III) age 40-80

Exclusion criteria

Exclusion criteria: significant hearing/vision loss, or significant somatosensory impairment. (Such that it may intervene with our methods) if a participant had undergone deep brain stimulation (by means of an interview) has unpredictable and long lasting off periods (by means of an interview)

Design outcomes

Primary

MeasureTime frame
Main study parameter for gait pattern: Stride length, stride frequency and walking speed.

Secondary

MeasureTime frame
Parameters for differences in gait stability: Center of mass velocity, center of mass medio-lateral deviation, interstep time variability. Next to these secondary outcome parameters, interlimb coordination will be assessed. Descriptive study parameters: - Clinical characteristics: Unified Parkinson*s Disease Rating Scale, - Walking performance: 10 meter walk test; freezing of Gait Questionnaire - Balance performance: Single leg stance test - Duration of the disease

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)